We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID-19 Infection-Preventing Clinical Deterioration.
- Authors
Seymour, Christopher W.; Bauchner, Howard; Golub, Robert M.
- Abstract
The article discusses the study "Fluvoxamine vs. Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized Clinical Trial," by E. J. Lenze, C. Mattar, C. F. Zorumski and colleagues, that was published within the issue. Topics covered include corticosteroids as the standard of care for patients with serious illness, preventing COVID-19 patients from deteriorating to serious illness, and the limitations of the study that was conducted during the COVID-19 pandemic.
- Subjects
FLUVOXAMINE; COVID-19; CORONAVIRUS disease treatment; DRUG efficacy; CLINICAL drug trials
- Publication
JAMA: Journal of the American Medical Association, 2020, Vol 324, Issue 22, p2300
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.2020.21720